578 related articles for article (PubMed ID: 28095420)
1. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
2. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
3. NMDA receptor channel gating control by the pre-M1 helix.
McDaniel MJ; Ogden KK; Kell SA; Burger PB; Liotta DC; Traynelis SF
J Gen Physiol; 2020 Apr; 152(4):. PubMed ID: 32221541
[TBL] [Abstract][Full Text] [Related]
4. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M
Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
[TBL] [Abstract][Full Text] [Related]
7. Altered zinc sensitivity of NMDA receptors harboring clinically-relevant mutations.
Serraz B; Grand T; Paoletti P
Neuropharmacology; 2016 Oct; 109():196-204. PubMed ID: 27288002
[TBL] [Abstract][Full Text] [Related]
8. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
Hughes BA; Woodward JJ
Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016
[TBL] [Abstract][Full Text] [Related]
9. A structurally derived model of subunit-dependent NMDA receptor function.
Gibb AJ; Ogden KK; McDaniel MJ; Vance KM; Kell SA; Butch C; Burger P; Liotta DC; Traynelis SF
J Physiol; 2018 Sep; 596(17):4057-4089. PubMed ID: 29917241
[TBL] [Abstract][Full Text] [Related]
10. Effects of GluN2A and GluN2B gain-of-function epilepsy mutations on synaptic currents mediated by diheteromeric and triheteromeric NMDA receptors.
Chen X; Keramidas A; Harvey RJ; Lynch JW
Neurobiol Dis; 2020 Jul; 140():104850. PubMed ID: 32247039
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic and structural determinants of NMDA receptor voltage-dependent gating and slow Mg2+ unblock.
Clarke RJ; Glasgow NG; Johnson JW
J Neurosci; 2013 Feb; 33(9):4140-50. PubMed ID: 23447622
[TBL] [Abstract][Full Text] [Related]
12. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
[TBL] [Abstract][Full Text] [Related]
13. Imprecision in Precision Medicine: Differential Response of a Disease-Linked GluN2A Mutant to NMDA Channel Blockers.
Gale JR; Kosobucki GJ; Hartnett-Scott KA; Aizenman E
Front Pharmacol; 2021; 12():773455. PubMed ID: 34776984
[TBL] [Abstract][Full Text] [Related]
14. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
[TBL] [Abstract][Full Text] [Related]
15. 7-Methoxyderivative of tacrine is a 'foot-in-the-door' open-channel blocker of GluN1/GluN2 and GluN1/GluN3 NMDA receptors with neuroprotective activity in vivo.
Kaniakova M; Kleteckova L; Lichnerova K; Holubova K; Skrenkova K; Korinek M; Krusek J; Smejkalova T; Korabecny J; Vales K; Soukup O; Horak M
Neuropharmacology; 2018 Sep; 140():217-232. PubMed ID: 30099049
[TBL] [Abstract][Full Text] [Related]
16. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
[TBL] [Abstract][Full Text] [Related]
17. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
18. Synaptic NMDA receptors in basolateral amygdala principal neurons are triheteromeric proteins: physiological role of GluN2B subunits.
Delaney AJ; Sedlak PL; Autuori E; Power JM; Sah P
J Neurophysiol; 2013 Mar; 109(5):1391-402. PubMed ID: 23221411
[TBL] [Abstract][Full Text] [Related]
19. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors.
Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M
Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756
[TBL] [Abstract][Full Text] [Related]
20. Triclosan-Evoked Neurotoxicity Involves NMDAR Subunits with the Specific Role of GluN2A in Caspase-3-Dependent Apoptosis.
Szychowski KA; Wnuk A; Rzemieniec J; Kajta M; Leszczyńska T; Wójtowicz AK
Mol Neurobiol; 2019 Jan; 56(1):1-12. PubMed ID: 29675573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
